Patents for C12P 21 - Preparation of peptides or proteins (112,499)
09/1996
09/25/1996EP0733110A1 Tuberous sclerosis 2 gene and uses thereof
09/25/1996EP0733109A1 Bmp-12, bmp-13 and tendon-inducing compositions thereof
09/25/1996EP0733108A1 Mutants of bone morphogenetic proteins
09/25/1996EP0733107A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY
09/25/1996EP0733106A1 Plant arabinogalactan protein (agp) genes
09/25/1996EP0733102A1 Reagents and methods for the detection of methotrexate
09/25/1996EP0733072A1 Antibody against carcinoembryonic antigen (cea)
09/25/1996EP0733071A1 Antagonists to chaperonin 10
09/25/1996EP0733070A1 Process for generating specific antibodies
09/25/1996EP0733069A1 Purified primate ctla-8 antigens and related reagents
09/25/1996EP0733068A1 METHODS AND COMPOSITIONS FOR THE SUPPRESSION OF $i(NEU) MEDIATED TRANSFORMATION
09/25/1996EP0733064A1 NUCLEIC ACIDS ENCODING A HOUSE DUST MITE ALLERGEN, $i(DER P) III, AND USES THEREFOR
09/25/1996EP0732941A1 Modulation of vascular cell adhesion molecule expression through novel oligonucleotide interactions
09/25/1996EP0732939A1 Preparation and use of immunoconjugates
09/25/1996EP0732933A1 Method of treating renal disease by administering igf-i and igfbp-3
09/25/1996EP0732932A1 Use of urinastatin-like compounds to prevent premature delivery
09/25/1996EP0732875A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5)
09/25/1996EP0587805B1 Bovine herpesvirus type 1 deletion mutants, vaccines based thereon, diagnostic kits for detection of bovine herpesvirus type 1
09/25/1996EP0511308B1 Chimeric immunoglobulin for cd4 receptors
09/25/1996EP0458940B1 Method for the quantitative detection of thyrotropine (tsh) or of anti-thyrotropine receptor autoantibodies (anti-tshr) using a recombinant thyrotropin receptor polypeptide and kit for conducting said method
09/25/1996EP0432249B1 Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore
09/25/1996CN1131950A Recombinant C140 receptor and its agonists and antagonists
09/25/1996CA2172451A1 Process for the immunologic determination of cortisol, especially urinary cortisol, and reagents used
09/25/1996CA2171668A1 Expression system which can be regulated
09/24/1996US5559223 Synthetic storage proteins with defined structure containing programmable levels of essential amino acids for improvement of the nutritional value of plants
09/24/1996US5559211 Biologically active product produced by streptococcus pyogenes and method of purification
09/24/1996US5559099 Penton base protein and methods of using same
09/24/1996US5559094 AspB1 insulin analogs
09/24/1996US5559027 Synergistic
09/24/1996US5559011 Nucleic acids encoding membrane-associated immunogens of mycobacterial and corresponding probes, vectors, and transformed host cells
09/24/1996US5559007 Secretion of hirudin from host cell, gene expression, major secretion product of lactococcus
09/24/1996US5558997 Monoclonal antibodies to mycosphaerella species
09/24/1996US5558864 Humanized and chimeric anti-epidermal growth factor receptor monoclonal antibodies
09/24/1996CA1338605C Gene encoding insecticidal protein and production of said protein using said gene
09/19/1996WO1996028569A1 Monoclonal antibody and antigen relating to human pulmonary adenocarcinoma and immunoassay method with the use of the same
09/19/1996WO1996028559A1 Method for the production of cationic peptides
09/19/1996WO1996028550A1 Human restrictin and nucleic acid sequences
09/19/1996WO1996028549A2 Hyaluronan receptor expressed in human umbilical vein endothelial cells
09/19/1996WO1996028548A1 Receptor activation by gas6
09/19/1996WO1996028547A1 Dermatomyositis-specific auto-antigen
09/19/1996WO1996028546A1 Human tumor necrosis factor receptor
09/19/1996WO1996028544A1 A protein-lipid conjugate, consisting of heparin binding protein (hbp) and a ceramide analogue, and its pharmaceutical use in treatment of conditions involving stress injury to cells
09/19/1996WO1996028474A1 Immunoassay using antibodies directed to the reaction product of enzymes used as labels
09/19/1996WO1996028472A1 Antigen composition against mycoplasma
09/19/1996WO1996017936A3 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease
09/19/1996WO1996017865A3 Genes and gene products for use in the diagnosis of degenerative nerve damage
09/19/1996DE4090006C2 Purified sciatic nerve ciliary neurotrophic factor
09/19/1996CA2215362A1 Method for the production of cationic peptides
09/19/1996CA2215357A1 Immunoassay using antibodies directed to the reaction product of enzymes used as labels
09/19/1996CA2214995A1 Hyaluronan receptor expressed in human umbilical vein endothelial cells
09/19/1996CA2214799A1 A protein-lipid conjugate, consisting of heparin binding protein (hbp) and a ceramide analogue, and its pharmaceutical use in treatment of conditions involving stress injury to cells
09/19/1996CA2189252A1 Human restrictin and nucleic acid sequences
09/18/1996EP0732404A1 Novel expression screening vector
09/18/1996EP0732403A1 Yeast expression systems with vectors having GAPDH promoters, and synthesis of HBsAg
09/18/1996EP0732340A2 Expression of porcine reproductive respiratory syndrome virus polypeptides in the same cell
09/18/1996EP0732104A1 Useful composition for the manufacture of vaccines containing particles bearing a hepatitis B virus surface antigen and polymerized human seric albumin receptor, animal cells able to produce such particles and process for their obtention
09/18/1996EP0731845A1 Homologous recombination antibody expression system for murine cells
09/18/1996EP0731842A1 Recombinant binding proteins and peptides
09/18/1996EP0731839A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition
09/18/1996EP0731838A1 Binding structures directed against the ca55.1 antigen
09/18/1996EP0731837A1 Bacteria used to produce stable fusion proteins and method for their identification
09/18/1996EP0731811A1 Chaperonin 10
09/18/1996EP0731806A1 SPECIFIC FUSION NUCLEIC ACIDS AND PROTEINS PRESENT IN HUMAN t(2;5) LYMPHOMA, METHODS OF DETECTION AND USES THEREOF
09/18/1996EP0731709A1 Novel neutrophil inhibitors
09/18/1996EP0731636A1 Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
09/18/1996EP0524958B1 Antigenic proteins of borrelia burgdorferi
09/18/1996CN1131463A Marking of products to establish identity and source
09/18/1996CN1131438A Protein having TPO activity
09/18/1996CN1131192A Recombinant mersacidin and method for production
09/17/1996US5556947 Monoclonal antibody recognizing a surface molecule on a subset of antigen-stimulated T cells and on certain malignancies of T and B cell origin
09/17/1996US5556769 Coupled replication-translation methods and kits for protein synthesis
09/17/1996US5556768 Method for preparing peptides and proteins utilizing ribosome
09/17/1996US5556753 DNA encoding human α1 adrenegric receptors and uses thereof
09/12/1996WO1996027673A1 Control of gene expression in plants by receptor mediated transactivation in the presence of a chemical ligand
09/12/1996WO1996027671A1 Subtilisin variants capable of cleaving substrates containing basic residues
09/12/1996WO1996027665A2 Neuron-restrictive silencer factor proteins
09/12/1996WO1996027612A1 Production in yeasts of stable antibody fragments
09/12/1996WO1996027611A1 A method for identifying a novel multidrug-resistance type
09/12/1996WO1996027610A1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon
09/12/1996WO1996027608A1 Process for producing a protein
09/12/1996WO1996027392A1 Antigen presenting system and methods for activation of t-cells
09/12/1996WO1996027385A1 Anti-obesity proteins
09/12/1996WO1996027292A1 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
09/12/1996WO1996027291A1 Bacillus thuringiensis isolates active against weevils
09/12/1996CA2214723A1 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria
09/12/1996CA2214283A1 Anti-obesity proteins
09/12/1996CA2214278A1 Bacillus thuringiensis isolates active against weevils
09/12/1996CA2214271A1 Neuron-restrictive silencer factor proteins
09/12/1996CA2212125A1 Process for producing a protein
09/11/1996EP0731170A1 Insect-resistant plants
09/11/1996EP0731167A1 Modular assembly of antibody genes, antibodies prepared thereby and use
09/11/1996EP0731165A2 Human T-cell line infected with HIV-2 which secretes functionally intact HIV-2 GP160
09/11/1996EP0731109A1 Purification of D-factor
09/11/1996EP0730661A1 Compounds with pth activity and recombinant dna vectors encoding same
09/11/1996EP0730660A1 Chimeric proteins including protease nexin-1 variants
09/11/1996EP0730659A1 METHOD FOR GENERATING A SUBTRACTED cDNA LIBRARY AND USES OF THE GENERATED LIBRARY
09/11/1996EP0730655A1 $i(ASPERGILLUS) EXPRESSION SYSTEM
09/11/1996EP0730652A1 Dna sequences for ammonium transporter, plasmids, bacteria, yeasts, plant cells and plants containing the transporter
09/11/1996EP0730651A1 Surface loop structural analogues of fibroblast growth factors
09/11/1996EP0730647A1 Dna sequence coding for a bmp receptor